Detalhe da pesquisa
1.
Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease.
Blood
; 123(24): 3832-42, 2014 Jun 12.
Artigo
Inglês
| MEDLINE | ID: mdl-24711661
2.
A newly identified 45-kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance.
Mol Oncol
; 18(2): 415-430, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38104968
3.
NIPA (Nuclear Interaction Partner of ALK) Is Crucial for Effective NPM-ALK Mediated Lymphomagenesis.
Front Oncol
; 12: 875117, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35646639
4.
Loss of the Fanconi anemia-associated protein NIPA causes bone marrow failure.
J Clin Invest
; 130(6): 2827-2844, 2020 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32338640